Cells communicate their health status through protein presentation, crucial for immune system surveillance.Cancer cells evade immune detection by exhibiting fewer recognizable proteins.Research at Weizmann Institute of Science disrupts cancer cell protein production to enhance immune targeting.Manipulating translation processes in cancer cells leads to abnormal protein presentation, triggering immune response.Immunotherapy leverages the immune system to combat tumors but faces challenges due to limited targets in certain cancer types.Disrupting translation in melanoma cells reveals potential new targets for immune response activation.Combining translation disruption with immunotherapy shows enhanced effectiveness in eradicating tumors in mouse models.Translational disruption may broaden immunotherapy candidacy criteria, benefiting more patients.Interrupting protein translation process can improve immune response to cancer, paving the way for innovative treatments.Future research aims to identify additional translation targets in diverse cancer types for personalized treatment approaches.